North Dakota State Investment Board’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.79M Buy
15,994
+50
+0.3% +$17.1K 0.24% 62
2026
Q1
$5.61M Sell
15,944
-2,879
-15% -$1.03M 0.24% 59
2025
Q4
$6.16M Buy
+18,823
New +$5.97M 0.23% 62

Other funds holding AMGN

North Dakota State Investment Board's AMGN Position: Q2 2026 in Review

North Dakota State Investment Board increased its Amgen (AMGN) stake by 0.31% in Q2 2026, buying an estimated $17.1K and bringing the position to 15,994 shares worth $5.79M. The position accounts for 0.24% of the portfolio, ranked #62.

North Dakota State Investment Board first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.16M in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • North Dakota State Investment Board held 15,994 shares of Amgen worth $5.79M as of Q2 2026.
  • North Dakota State Investment Board bought 50 Amgen shares in Q2 2026, an estimated $17.1K.
  • Amgen made up 0.24% of North Dakota State Investment Board's portfolio in Q2 2026, its #62 holding.
  • North Dakota State Investment Board first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • North Dakota State Investment Board's Amgen position peaked at $6.16M in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on North Dakota State Investment Board's 13F filing for Q2 2026, filed 4 Aug 2026.